[
    {
        "gene_name":"C2",
        "genomic_position":"6:31895254-31913449(+)",
        "cds_mutation":"c.3532C>T",
        "aa_mutation":"p.Q1178*",
        "disease":"Thyroid Gland Carcinoma",
        "therapy_rank":4,
        "response_to_drug":"Sensitivity",
        "therapies":"Everolimus",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:25295501"
    },
    {
        "gene_name":"TSC2",
        "genomic_position":"16:2097466-2138713(+)",
        "cds_mutation":"c.3532C>T",
        "aa_mutation":"p.Q1178*",
        "disease":"Thyroid Gland Carcinoma",
        "therapy_rank":4,
        "response_to_drug":"Sensitivity",
        "therapies":"Everolimus",
        "description":null,
        "rs_value":"45517297",
        "pmid":"PubMed:25295501"
    },
    {
        "gene_name":"GNAS",
        "genomic_position":"20:57427769-57486247(+)",
        "cds_mutation":"R201H",
        "aa_mutation":"p.R201H",
        "disease":"Thyroid Gland Follicular Carcinoma",
        "therapy_rank":4,
        "response_to_drug":"Sensitivity",
        "therapies":"Radioactive Iodine",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:26788326"
    },
    {
        "gene_name":"ALK",
        "genomic_position":"2:29415640-30144432(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"thyroid | carcinoma | anaplastic carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Crizotinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:24687827"
    },
    {
        "gene_name":"ALK",
        "genomic_position":"2:29415640-30144432(-)",
        "cds_mutation":"Fusion",
        "aa_mutation":"Fusion",
        "disease":"Thyroid Gland Anaplastic Carcinoma",
        "therapy_rank":4,
        "response_to_drug":"Sensitivity",
        "therapies":"Crizotinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:24687827"
    },
    {
        "gene_name":"BRAF",
        "genomic_position":"7:140434279-140624564(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"thyroid | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Pertuzumab,Vemurafenib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:29320312"
    },
    {
        "gene_name":"BRAF",
        "genomic_position":"7:140434279-140624564(-)",
        "cds_mutation":"c.1799T>A",
        "aa_mutation":"p.V600E",
        "disease":"Thyroid Gland Anaplastic Carcinoma",
        "therapy_rank":2,
        "response_to_drug":"Sensitivity",
        "therapies":"Pertuzumab,Vemurafenib",
        "description":null,
        "rs_value":"113488022",
        "pmid":"PubMed:29320312"
    },
    {
        "gene_name":"BRAF",
        "genomic_position":"7:140434279-140624564(-)",
        "cds_mutation":"c.1799T>A",
        "aa_mutation":"p.V600E",
        "disease":"thyroid | carcinoma | NS",
        "therapy_rank":2,
        "response_to_drug":"Sensitivity",
        "therapies":"Pertuzumab,Vemurafenib",
        "description":null,
        "rs_value":"113488022",
        "pmid":"PubMed:29320312"
    },
    {
        "gene_name":"BRAF",
        "genomic_position":"7:140434279-140624564(-)",
        "cds_mutation":"V600E\/K",
        "aa_mutation":"p.V600E\/K",
        "disease":"thyroid | carcinoma | anaplastic carcinoma",
        "therapy_rank":2,
        "response_to_drug":"Sensitivity",
        "therapies":"Pertuzumab,Vemurafenib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:29320312"
    },
    {
        "gene_name":"BRAF",
        "genomic_position":"7:140434279-140624564(-)",
        "cds_mutation":"c.1799T>A",
        "aa_mutation":"p.V600E",
        "disease":"thyroid | carcinoma | anaplastic carcinoma",
        "therapy_rank":2,
        "response_to_drug":"Sensitivity",
        "therapies":"Pertuzumab,Vemurafenib",
        "description":null,
        "rs_value":"113488022",
        "pmid":"PubMed:29320312"
    },
    {
        "gene_name":"BRAF",
        "genomic_position":"7:140434279-140624564(-)",
        "cds_mutation":"c.1799T>A",
        "aa_mutation":"p.V600E",
        "disease":"thyroid | carcinoma | papillary carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Pertuzumab,Vemurafenib",
        "description":null,
        "rs_value":"113488022",
        "pmid":"PubMed:29320312"
    },
    {
        "gene_name":"BRAF",
        "genomic_position":"7:140434279-140624564(-)",
        "cds_mutation":"c.1799T>A",
        "aa_mutation":"p.V600E",
        "disease":"Thyroid Gland Papillary Carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Pertuzumab,Vemurafenib",
        "description":null,
        "rs_value":"113488022",
        "pmid":"PubMed:29320312"
    },
    {
        "gene_name":"BRAF",
        "genomic_position":"7:140434279-140624564(-)",
        "cds_mutation":"c.1799T>A",
        "aa_mutation":"p.V600E",
        "disease":"Thyroid Gland Anaplastic Carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Pertuzumab,Vemurafenib",
        "description":null,
        "rs_value":"113488022",
        "pmid":"PubMed:29320312"
    },
    {
        "gene_name":"BRAF",
        "genomic_position":"7:140434279-140624564(-)",
        "cds_mutation":"V600E\/M",
        "aa_mutation":"p.V600E\/M",
        "disease":"thyroid | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Pertuzumab,Vemurafenib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:29320312"
    },
    {
        "gene_name":"BRAF",
        "genomic_position":"7:140434279-140624564(-)",
        "cds_mutation":"c.1799T>A",
        "aa_mutation":"p.V600E",
        "disease":"thyroid | carcinoma | anaplastic carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Pertuzumab,Vemurafenib",
        "description":null,
        "rs_value":"113488022",
        "pmid":"PubMed:29320312"
    },
    {
        "gene_name":"BRAF",
        "genomic_position":"7:140434279-140624564(-)",
        "cds_mutation":"c.1798delinsTACA",
        "aa_mutation":"p.V600",
        "disease":"thyroid | carcinoma | anaplastic carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Pertuzumab,Vemurafenib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:29320312"
    },
    {
        "gene_name":"BRAF",
        "genomic_position":"7:140434279-140624564(-)",
        "cds_mutation":"c.1799T>A",
        "aa_mutation":"p.V600E",
        "disease":"thyroid | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Pertuzumab,Vemurafenib",
        "description":null,
        "rs_value":"113488022",
        "pmid":"PubMed:29320312"
    },
    {
        "gene_name":"BRAF",
        "genomic_position":"7:140434279-140624564(-)",
        "cds_mutation":"c.1799T>A",
        "aa_mutation":"p.V600E",
        "disease":"Thyroid Gland Papillary Carcinoma",
        "therapy_rank":4,
        "response_to_drug":"Sensitivity",
        "therapies":"Pertuzumab,Vemurafenib",
        "description":null,
        "rs_value":"113488022",
        "pmid":"PubMed:29320312"
    },
    {
        "gene_name":"BRAF",
        "genomic_position":"7:140434279-140624564(-)",
        "cds_mutation":"c.1799T>A",
        "aa_mutation":"p.V600E",
        "disease":"Thyroid Gland Anaplastic Carcinoma",
        "therapy_rank":4,
        "response_to_drug":"Sensitivity",
        "therapies":"Pertuzumab,Vemurafenib",
        "description":null,
        "rs_value":"113488022",
        "pmid":"PubMed:29320312"
    },
    {
        "gene_name":"MTOR",
        "genomic_position":"1:11166592-11322564(-)",
        "cds_mutation":"c.6324C>A",
        "aa_mutation":"p.F2108L",
        "disease":"Thyroid Gland Carcinoma",
        "therapy_rank":4,
        "response_to_drug":"Resistance",
        "therapies":"Everolimus",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:25295501"
    },
    {
        "gene_name":"MTOR",
        "genomic_position":"1:11166592-11322564(-)",
        "cds_mutation":"c.939C>A",
        "aa_mutation":"p.F313L",
        "disease":"anaplastic_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Everolimus",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:25295501"
    },
    {
        "gene_name":"MTOR",
        "genomic_position":"1:11166592-11322564(-)",
        "cds_mutation":"c.6324C>A",
        "aa_mutation":"p.F2108L",
        "disease":"anaplastic_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Everolimus",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:25295501"
    },
    {
        "gene_name":"RET",
        "genomic_position":"10:43572475-43625799(+)",
        "cds_mutation":"c.2753T>C",
        "aa_mutation":"p.M918T",
        "disease":"Thyroid Gland Medullary Carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Selpercatinib",
        "description":null,
        "rs_value":"74799832",
        "pmid":"PubMed:nan"
    },
    {
        "gene_name":"RET",
        "genomic_position":"10:43572475-43625799(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"thyroid | carcinoma | medullary carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Selpercatinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:nan"
    },
    {
        "gene_name":"RET",
        "genomic_position":"10:43572475-43625799(+)",
        "cds_mutation":"c.1900T>C",
        "aa_mutation":"p.C634R",
        "disease":"thyroid | carcinoma | medullary carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Selpercatinib",
        "description":null,
        "rs_value":"75076352'], 'CLNDISDBINCL'MONDO:MONDO:0008234', 'MeSH:D018813', 'MedGen:C0025268', 'OMIM:171400', 'Orphanet:ORPHA247698', 'SNOMED_CT:61808009'], 'CLNDNINCL'Multiple_endocrine_neoplasia', '_type_2a'], 'CLNSIGINCL'13906:Pathogenic",
        "pmid":"PubMed:nan"
    },
    {
        "gene_name":"RET",
        "genomic_position":"10:43572475-43625799(+)",
        "cds_mutation":"c.2753T>C",
        "aa_mutation":"p.M918T",
        "disease":"thyroid | carcinoma | medullary carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Selpercatinib",
        "description":null,
        "rs_value":"74799832",
        "pmid":"PubMed:nan"
    },
    {
        "gene_name":"RET",
        "genomic_position":"10:43572475-43625799(+)",
        "cds_mutation":"fusions",
        "aa_mutation":"fusions",
        "disease":"thyroid | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Selpercatinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:nan"
    },
    {
        "gene_name":"RET",
        "genomic_position":"10:43572475-43625799(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"thyroid | carcinoma | medullary carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Selpercatinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:nan"
    },
    {
        "gene_name":"RET",
        "genomic_position":"10:43572475-43625799(+)",
        "cds_mutation":"c.2753T>C",
        "aa_mutation":"p.M918T",
        "disease":"Thyroid Gland Medullary Carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Selpercatinib",
        "description":null,
        "rs_value":"74799832",
        "pmid":"PubMed:nan"
    },
    {
        "gene_name":"RET",
        "genomic_position":"10:43572475-43625799(+)",
        "cds_mutation":"c.2753T>C",
        "aa_mutation":"p.M918T",
        "disease":"thyroid | carcinoma | medullary carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Selpercatinib",
        "description":null,
        "rs_value":"74799832",
        "pmid":"PubMed:nan"
    },
    {
        "gene_name":"RET",
        "genomic_position":"10:43572475-43625799(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"thyroid | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Selpercatinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:nan"
    },
    {
        "gene_name":"RET",
        "genomic_position":"10:43572475-43625799(+)",
        "cds_mutation":"V804M_or_RET_M918T",
        "aa_mutation":"p.V804M_or_RET_M918T",
        "disease":"thyroid | carcinoma | medullary carcinoma",
        "therapy_rank":4,
        "response_to_drug":"Sensitivity",
        "therapies":"Selpercatinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:nan"
    },
    {
        "gene_name":"RET",
        "genomic_position":"10:43572475-43625799(+)",
        "cds_mutation":"fusion_COSF1231",
        "aa_mutation":"fusion_COSF1231",
        "disease":"thyroid | carcinoma | medullary carcinoma",
        "therapy_rank":4,
        "response_to_drug":"Sensitivity",
        "therapies":"Selpercatinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:nan"
    },
    {
        "gene_name":"F2",
        "genomic_position":"11:46740730-46761056(+)",
        "cds_mutation":"c.6324C>A",
        "aa_mutation":"p.F2108L",
        "disease":"Thyroid Gland Carcinoma",
        "therapy_rank":4,
        "response_to_drug":"Resistance",
        "therapies":"Everolimus",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:25295501"
    },
    {
        "gene_name":"HRAS",
        "genomic_position":"11:532243-535550(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"thyroid | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Tipifarnib",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT02383927"
    },
    {
        "gene_name":"FGFR1",
        "genomic_position":"8:38268656-38325363(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"thyroid | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Pazopanib",
        "description":null,
        "rs_value":null,
        "pmid":"DOI:NCT01813136"
    },
    {
        "gene_name":"NTRK1",
        "genomic_position":"1:156830686-156851434(+)",
        "cds_mutation":"fusions_or_NTRK2_fusions_or_NTRK3_fusions",
        "aa_mutation":"fusions_or_NTRK2_fusions_or_NTRK3_fusions",
        "disease":"thyroid | carcinoma | NS",
        "therapy_rank":2,
        "response_to_drug":"Sensitivity",
        "therapies":"Taletrectinib",
        "description":null,
        "rs_value":null,
        "pmid":"DOI:NCT02279433"
    },
    {
        "gene_name":"NTRK1",
        "genomic_position":"1:156830686-156851434(+)",
        "cds_mutation":"fusions",
        "aa_mutation":"fusions",
        "disease":"thyroid | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Taletrectinib",
        "description":null,
        "rs_value":null,
        "pmid":"DOI:NCT02279433"
    },
    {
        "gene_name":"CD274",
        "genomic_position":"9:5450525-5470547(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"thyroid | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Cabozantinib + Ipilimumab + Nivolumab",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT03914300"
    },
    {
        "gene_name":"CD274",
        "genomic_position":"9:5450525-5470547(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"thyroid | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Cabozantinib + Ipilimumab + Nivolumab",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT03914300"
    },
    {
        "gene_name":"TP53",
        "genomic_position":"17:7571720-7590856(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"thyroid | carcinoma | anaplastic carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Cisplatin + Crolibulin",
        "description":null,
        "rs_value":null,
        "pmid":"DOI:NCT01240590"
    },
    {
        "gene_name":"KRAS",
        "genomic_position":"12:25362365-25403737(-)",
        "cds_mutation":"G12_or_HRAS_G13_or_HRAS_Q61_or_KRAS_G12_or_KRAS_G13_or_KRAS_Q61_or_NRAS_G12_or_NRAS_G13_or_NRAS_Q61",
        "aa_mutation":"p.G12_or_HRAS_G13_or_HRAS_Q61_or_KRAS_G12_or_KRAS_G13_or_KRAS_Q61_or_NRAS_G12_or_NRAS_G13_or_NRAS_Q61",
        "disease":"thyroid | carcinoma | NS",
        "therapy_rank":2,
        "response_to_drug":"Sensitivity",
        "therapies":"Radioiodine + Trametinib",
        "description":null,
        "rs_value":null,
        "pmid":"DOI:NCT02152995"
    },
    {
        "gene_name":"NRAS",
        "genomic_position":"1:115247090-115259515(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"thyroid | carcinoma | NS",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Vemurafenib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:30036146"
    },
    {
        "gene_name":"NRAS",
        "genomic_position":"1:115247090-115259515(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"thyroid | carcinoma | NS",
        "therapy_rank":2,
        "response_to_drug":"Sensitivity",
        "therapies":"Vemurafenib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:30036146"
    },
    {
        "gene_name":"NRAS",
        "genomic_position":"1:115247090-115259515(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"thyroid | carcinoma | NS",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Vemurafenib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:30036146"
    },
    {
        "gene_name":"NRAS",
        "genomic_position":"1:115247090-115259515(-)",
        "cds_mutation":"c.?",
        "aa_mutation":"p.Q61K",
        "disease":"papillary_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Vemurafenib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:30036146"
    }
]